EPAS1 and Hepatic fibrosis: In addition, silencing HIF-1α plus HIF-2α was significantly weaker at inhibiting fibrosis compared with VHL overexpression, indicating that there may be an HIF-1α- and HIF-2α-independent pathway for VHL to attenuate liver fibrosis.